Clinical trial · Interventional
Physiotherapy in Hematopoietic Stem Cell Transplantation
Effectiveness of Physiotherapy in the Prevention of Physical Sequelae in Patients Treated With Hematopoietic Stem Cell Transplantation. A Pilot Study.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Research project with patients undergoing allogeneic hematopoietic transplantation in the hematology and hemotherapy Clinical Hospital Universitario Virgen de la Arrixaca. The main objective is to assess the differences in skeletal muscle and functional variables in the experimental group underwent a physiotherapy treatment that takes place during the pre-and post-transplant period, compared to a control group.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematologic Malignancy | Hematopoietic and Lymphoid Cell Neoplasm | ALIAS | 0.90 |
| Stem Cell Transplantation | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Physiotherapy in patients with stem cell transplantation | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Physiotherapy exercises
- description
- Strength exercises for the muscles proximal upper limbs and lower limbs and proprioception exercises
- interventionNames
- Other: Physiotherapy in patients with stem cell transplantation
- type
- NO_INTERVENTION
- label
- Control group
- description
- Patients undergoing allogeneic transplantation without treatment of physiotherapy
Primary outcomes (11)
- measure
- Changes in joint range of motion
- timeFrame
- Screening visit (one month before hospital admission); at the time of admission (±3 days); ±2 days before transplantation; after hospital discharge (± 3 days); and at 3 and 6 months after transplantation (± 3 days)
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Patients aged between 18 and 70 years. * Patients with a diagnosis of hematologic malignancy that will be subjected to hematopoietic transplantation. * Patients offer sufficient guarantee adherence to protocol. * Patients who have previously signed informed consent. Exclusion Criteria: * Patients with inability to walk, before treatment. * Patients whose medical judgment contraindicated inclusion in a physiotherapy intervention. * Patients with psychotic traits, brain damage or senility prevention of the correct understanding of physical therapy. * Patients with inability to sign informed consent or understanding.
References
Publications (0)
Data not yet available